1. Home
  2. LGND vs ALG Comparison

LGND vs ALG Comparison

Compare LGND & ALG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • ALG
  • Stock Information
  • Founded
  • LGND 1987
  • ALG 1955
  • Country
  • LGND United States
  • ALG United States
  • Employees
  • LGND 68
  • ALG N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • ALG Industrial Machinery/Components
  • Sector
  • LGND Health Care
  • ALG Industrials
  • Exchange
  • LGND Nasdaq
  • ALG Nasdaq
  • Market Cap
  • LGND 2.2B
  • ALG 2.6B
  • IPO Year
  • LGND 1992
  • ALG 1993
  • Fundamental
  • Price
  • LGND $163.73
  • ALG $209.03
  • Analyst Decision
  • LGND Strong Buy
  • ALG Buy
  • Analyst Count
  • LGND 8
  • ALG 2
  • Target Price
  • LGND $144.71
  • ALG $242.50
  • AVG Volume (30 Days)
  • LGND 139.7K
  • ALG 79.6K
  • Earning Date
  • LGND 08-05-2025
  • ALG 10-30-2025
  • Dividend Yield
  • LGND N/A
  • ALG 0.57%
  • EPS Growth
  • LGND N/A
  • ALG N/A
  • EPS
  • LGND N/A
  • ALG 9.82
  • Revenue
  • LGND $181,488,000.00
  • ALG $1,596,647,000.00
  • Revenue This Year
  • LGND $18.41
  • ALG $1.20
  • Revenue Next Year
  • LGND $18.87
  • ALG $5.89
  • P/E Ratio
  • LGND N/A
  • ALG $21.27
  • Revenue Growth
  • LGND 53.40
  • ALG N/A
  • 52 Week Low
  • LGND $81.74
  • ALG $157.07
  • 52 Week High
  • LGND $129.90
  • ALG $233.29
  • Technical
  • Relative Strength Index (RSI)
  • LGND 74.67
  • ALG 38.48
  • Support Level
  • LGND $158.40
  • ALG $210.49
  • Resistance Level
  • LGND $161.89
  • ALG $219.13
  • Average True Range (ATR)
  • LGND 3.76
  • ALG 5.68
  • MACD
  • LGND -0.07
  • ALG -1.48
  • Stochastic Oscillator
  • LGND 93.80
  • ALG 5.68

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About ALG Alamo Group Inc.

Alamo Group Inc is engaged in the design, manufacture, and servicing of high-quality vegetation management and infrastructure maintenance equipment for governmental, industrial and agricultural use. Its products include tractor-mounted and self-propelled mowers, zero-turn mowers, agricultural implements, tree and branch chippers, forestry/wood recycling equipment, street and parking lot sweepers, leaf and debris collection equipment, truck mounted highway attenuator trucks, vacuum trucks, hydro-excavation equipment, telescopic boom excavators, and snow removal equipment. The company's reportable segments are Vegetation Management and Industrial Equipment. It generates a majority of revenue from Vegetation Management. Geographically, it generates the majority of revenue from United States.

Share on Social Networks: